European Neurological Review
Volume 5 • Issue 1
Cover image: Myelinated nerve fibres. © Steve Gschmeissner/Science Photo Library
Managing Editor Tami Hughes
Sub-editorial Manager Claire Dunn
Sub-editors
Andrew McCulloch Claire Vinent
Technical Editors Patrick Wong James Gilbart Angela Chan
Design Manager Eliza Albie
Artworker Ian Shoobridge
Production Manager Louise Monrose
Key Account Director Tim Sheldrick
Senior Account Manager Matthew Goodwin
Medical Sales Director Barney Kent
Publishing Director Fergus Brunning
Editorial Contact Tami Hughes
T: +44 (0) 20 7452 5232 F: +44 (0) 20 7452 5050
E:
tami.hughes@
touchbriefings.com
Circulation Contact Miriam Oppenheim
E:
miriam.oppenheim@touchbriefings.com
Sales Contact Matthew Goodwin T: +44 (0) 20 7452 5361 F: +44 (0) 20 7452 5606
E:
matthew.goodwin@touchbriefings.com
Association Contact Xue Han
T: +44 (0) 20 7452 5042 F: +44 (0) 20 7452 5606
E:
xue.han@touchbriefings.com European Neurological Review is audited by BPA Worldwide. Published by Touch Briefings. Touch Briefings is the trading name of Business Briefings Ltd, a Touch Group plc company.
All information obtained by Business Briefings Ltd and each of the contributors from various sources is as current and accurate as possible. However, due to human or mechanical errors, Business Briefings Ltd and the contributors cannot guarantee the accuracy, adequacy or completeness of any information, and cannot be held responsible for any errors or omissions, or for the results obtained from the use thereof.
Where opinion is expressed, it is that of the authors and does not necessarily coincide with the editorial views of Business Briefings Ltd. Statistical and financial data in this publication have been compiled on the basis of factual information and do not constitute any investment advertisement or investment advice.
©2010 All rights reserved ISSN: 1758-3837 Johan Aarli
Professor, Department of Neurology, University of Bergen
Giuliano Avanzi Professor, and Director, Department of Experimental Research and Diagnosis, National Neurological Institute ‘Carlo Besta’
Mary Baker
President, European Federation of Neurological Associations (EFNA), and Past President, European Parkinson’s Disease Association (EPDA)
Sir Michael Bond Emeritus Professor of Psychological Medicine, University of Glasgow
Tamás Dóczi
Head, Research Unit, Department of Neurosurgery, Medical School, University of Pécs
Leslie J Findley Senior Consultant
Neurologist, Nuffield Health Brentwood Hospital
Arne Hagen
Past President, Stroke Alliance for Europe (SAFE)
Editorial Board Wolf-Dieter Heiss
Professor, Max Planck Institute for Neurological Research
Peter Jenner Professor, and Head, Neurodegenerative Diseases Research Group (NDRG), School of Health and Biomedical Sciences, King’s College London
Jürg Kesselring Professor, and Head, Department of Neurorehabilitation, Rehabilitation Centre, Neuroscience Centre Zurich, University of Zurich
Dawn Langdon
Reader in Neuropsychology, Royal Holloway, University of London
Marco Leonardi
Professor of Neuroradiology, Bologna University, Bellaria Hospital
Susanna Lindvall Vice President, European Parkinson’s Disease Association (EPDA)
Ioannis Milonas Professor, and Chairman, Department of Neurology, Thessaloniki Medical School, Aristotle University
Jacques L De Reuck Professor of Neurology, Stroke Research Team, University Hospital, Lille
Gerard Said
Consultant Neurologist, Fédération des Maladies Neurologiques, Hôpital de la Salpêtrière, Paris
Johannes Schramm Professor, and Chairman, Department of Neurosurgery, University of Bonn
Martin Schumacher Professor, and Head, Neuroradiology, University Hospital Freiburg
Bruno Vellas
Professor, Alzheimer’s Disease Research Clinical Centre, Toulouse University Hospital, and Principal Investigator, European Alzheimer’s Disease Consortium (EADC)
European Neurological Review wishes to thank the organisations below for their assistance. This does not constitute any official endorsement.
European Neurological Review acknowledges the financial assistance of the following companies in the publication of this edition: Actelion Ltd., Biogen Idec, Inc., NordicNeuroLab AS, Novartis Pharma AG, SHS International Ltd and Solvay Pharmaceuticals GmbH.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116